Navigation Links
Markey receives $6.25 million to study deadly blood and bone marrow disease
Date:5/22/2012

LEXINGTON, Ky. (May 17, 2012) The University of Kentucky Markey Cancer Center has received more than $6 million to study a deadly blood and bone marrow disease often caused by chemotherapy or radiation treatments. A $5 million grant from the Edward P. Evans Foundation, along with a $1.25 million donor gift, will fund research of myelodysplastic syndrome (MDS).

The Evans Foundation grant will fund five research labs over five years, including three labs at UK, one at Cincinnati Children's Hospital, and one at the University of Arkansas. The $1.25 million gift, given to UK through the Markey Cancer Foundation by an anonymous donor, will also fund the laboratories.

"This transformational gift from the Evans Foundation and the donor's generous matching gift will support and further clinical and investigative research efforts which are fundamental in our goal to serve not only as a comprehensive regional cancer center but also a nationally recognized leader in cancer care," said Dr. Michael Karpf, UK executive vice president for health affairs.

A major risk factor for MDS is past exposure to chemotherapy or radiation treatments in other words, patients who have received treatment for solid tumors, particularly breast or prostate cancers, have a much higher chance of developing this disease. Edward P. Evans, namesake of the foundation, was a Virginia businessman and thoroughbred owner who raced and sold his horses here in Lexington, Ky. He developed MDS after he received radiation treatment for prostate cancer and ultimately succumbed to the disease. In his will, he appointed four trustees to create the Edward P. Evans Foundation with the specific goal of funding MDS research.

The Edward P. Evans Foundation released the following statement in regards to awarding the research grant: "We are excited to encourage cooperation among organizations engaging in research related to diseases like myelodysplastic syndrome, leukemia and chr
'/>"/>

Contact: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UC San Diego Superfund Research Program receives $15 million grant renewal
2. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
3. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
4. LA BioMed receives Grand Challenges Explorations grant
5. Boston researcher, surgical oncologist receives national award
6. Neuropsychologist receives University of Houstons highest faculty honor
7. MU receives national award for using mind-body approach to improve health
8. Loyola Cancer Center receives Outstanding Achievement Award
9. Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research
10. A.J. Drexel Autism Institute receives $1.5 million from the Charles and Barbara Close Foundation
11. National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MA (PRWEB) June 02, 2015 Join us ... Anniversary Awareness Walk in Honor of Rhonda Martin , who ... members have since dedicated their resources to raising awareness and ... seeks to raise awareness in hopes that there will be ... , All are welcome and encouraged to join the ...
(Date:6/2/2015)... 2015 “We want men to realize the ... rays”, states Marta Phillips, owner of SunGrubbies.com, “that is ... and sun accessories that work well for outdoor activities.” , ... Sometimes sun damage can take up to thirty years to ... areas for skin cancer to occur. That is why ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into the NAPW VIP Professional Woman of ... distinction for leadership in academics. With more than 700,000 ... the nation’s leading networking organization exclusively for professional women. ... distinction,” said NAPW President Star Jones. “She is a ...
(Date:6/1/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Woman of ... distinction for leadership in mental health. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor," said NAPW President Star Jones. "Her knowledge ...
(Date:6/1/2015)... June 01, 2015 Ticket Down announces that ... NBA Western Conference Finals and now will face the Cleveland ... be held at the Oracle Arena in Oakland and the ... 2014-15 National Basketball Association season, the Golden State Warriors were ... a team that learned from their playoff failures from the ...
Breaking Medicine News(10 mins):Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3
... ... Workforce Development, in partnership with New York Downtown Hospital gave a new home to ... St. Vincent’s Hospital. , , ... New York, NY (Vocus) May 20, 2010 -- BMCC’s Center for ...
... , ... Sullivan discusses his induction and newfound opportunity to mentor young people. , ... (Vocus) May 20, 2010 -- Chicago trial ... Cooney & Conway Chair in Advocacy. Sullivan told journalists the appointment was “an honor” and ...
... Recipe Contest is ... ... -- Hit morning show airing on Lifetime Television “The Balancing Act,” and Chicken of the ... Chicken of the Sea SuperCook, someone who can turn simple dishes into super meals., , ...
... Drugs to treat anxiety and sleep disorders are still being ... increasingly so for baby boomers despite warnings against long-term ... Published online in the journal Health Policy , the ... Policy Research (CHSPR) is the first of its kind to ...
... ... to affect change in the lives of orphaned and vulnerable children in Africa, launches its third ... on May 7th each year. , ... Angeles, CA (Vocus) May 19, 2010 -- NextAid , a Los Angeles-based nonprofit organization harnessing ...
... to any one child remains low , WEDNESDAY, May 19 ... almost twice as likely to have autism as other children, ... or born prematurely also seemed to up the risk of ... researchers asked 111 women taking part in the Nurses, Health ...
Cached Medicine News:Health News:St. Vincent's Hospital Closes—and BMCC Rescues its Paramedic Program 2Health News:Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy 2Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 2Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 3Health News:Long-term use of anti-anxiety drugs continues in B.C. despite known health risks: UBC study 2Health News:NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day 2Health News:NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day 3Health News:NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day 4Health News:NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day 5Health News:IVF, Fertility Drugs Might Boost Autism Risk 2Health News:IVF, Fertility Drugs Might Boost Autism Risk 3Health News:IVF, Fertility Drugs Might Boost Autism Risk 4
(Date:6/2/2015)... , June 2, 2015 ... American Society of Clinical Oncology    PharmaMar ... 3 SAR3007, resi noti dal dipartimento Ricerca e sviluppo ... significativo miglioramento della sopravvivenza libera da progressione (PFS) dopo ... trattamento con dacarbazina in pazienti con liposarcoma (LPS) o ...
(Date:6/2/2015)... et MADRID , June ... orale (extrait 10503) effectuée lors de la réunion ... PharmaMar communique que Janssen Research & ... de l,étude multicentrique de phase III SAR3007 qui ... progression (PFS) avec la trabectédine (YONDELIS ® ) ...
(Date:6/1/2015)... 2015 Amgen (NASDAQ: AMGN ) ... Phase 1b study to evaluate the safety and ... in combination with Roche,s investigational anti-PDL1 therapy, atezolizumab ... breast cancer and colorectal cancer with liver metastases. ... immunotherapy designed to selectively replicate in tumors (but ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 2PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 3PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 4PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 5PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7
... -- Mindray Medical International Limited (NYSE: MR ... devices worldwide, today announced updates on new product launches ... the first half of the year, the company successfully ... product lines. These include: a new anesthesia machine, a ...
... Janssen Pharmaceuticals, Inc. today announced a definitive ... Dermatologics division in the U.S. to subsidiaries of ... in cash. The divestiture of Ortho Dermatologics, assets ... sold in the U.S.   The ...
Cached Medicine Technology:Mindray Medical Provides Mid-Year Update on Product Development 2Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division 2
... This type of anchor is generally utilized when ... directly into the bone. Unlike other anchors that ... anchor does not have that limitation. The only ... is a mallet. The 4.4mm Stainless Steel Anchor ...
... with Yasushi Nakao, M.D., Smith & ... to flexor,tendon release for fingers and ... invasive approach is designed to decrease ... element of releasing the A1 pulley ...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: